Old Port Advisors’s GSK GSK Stock Holding History

Old Port Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.65M	Buy	69,539 +874	+1%	+$46.2K	0.72%	33
2026 Q1	$3.79M	Buy	68,665 +338	+0.5%	+$18.3K	0.87%	32
2025 Q4	$3.35M	Buy	68,327 +812	+1%	+$37.9K	0.82%	33
2025 Q3	$2.91M	Buy	67,515 +2,951	+5%	+$115K	0.73%	37
2025 Q2	$2.48M	Buy	64,564 +1,965	+3%	+$75.1K	0.68%	42
2025 Q1	$2.43M	Buy	62,599 +4,782	+8%	+$175K	0.72%	46
2024 Q4	$1.96M	Sell	57,817 -4,468	-7%	-$161K	0.56%	59
2024 Q3	$2.55M	Sell	62,285 -1,423	-2%	-$58.2K	0.71%	45
2024 Q2	$2.45M	Sell	63,708 -1,691	-3%	-$71.1K	0.73%	43
2024 Q1	$2.8M	Buy	65,399 +3,691	+6%	+$152K	0.86%	37
2023 Q4	$2.29M	Sell	61,708 -3,662	-6%	-$131K	0.76%	46
2023 Q3	$2.37M	Buy	+65,370	New	+$2.32M	0.86%	39
2023 Q1	$2.4M	Buy	64,134 +3,959	+7%	+$139K	0.86%	39
2022 Q4	$2.11M	Buy	60,175 +381	+0.6%	+$12.7K	0.8%	41
2022 Q3	$1.82M	Buy	59,794 +242	+0.4%	+$9.17K	0.72%	39
2022 Q2	$3.22M	Sell	59,552 -12	-0%	-$662	1.25%	12
2022 Q1	$3.27M	Sell	59,564 -151	-0.3%	-$8.2K	1.11%	19
2021 Q4	$3.24M	Sell	59,715 -415	-0.7%	-$21.6K	1.1%	22
2021 Q3	$2.87M	Buy	60,130 +450	+0.8%	+$22.6K	1.04%	26
2021 Q2	$3.02M	Buy	59,680 +308	+0.5%	+$14.8K	1.09%	26
2021 Q1	$2.65M	Sell	59,372 -1,045	-2%	-$47.4K	1.04%	31
2020 Q4	$2.85M	Sell	60,417 -549	-0.9%	-$25.2K	1.24%	23
2020 Q3	$2.87M	Buy	60,966 +1,144	+2%	+$57.3K	1.42%	19
2020 Q2	$3.05M	Buy	59,822 +1,376	+2%	+$70.6K	1.6%	16
2020 Q1	$2.77M	Buy	58,446 +500	+0.9%	+$26.7K	1.69%	12
2019 Q4	$3.37M	Sell	57,946 -60	-0.1%	-$3.34K	1.63%	13
2019 Q3	$3.04M	Buy	58,006 +406	+0.7%	+$20.9K	1.59%	12
2019 Q2	$2.98M	Buy	57,600 +1,526	+3%	+$76.6K	1.53%	15
2019 Q1	$2.93M	Buy	56,074 +893	+2%	+$44.6K	1.54%	15
2018 Q4	$2.69M	Buy	+55,181	New	+$2.72M	1.51%	18
2018 Q2	$2.71M	Buy	+53,782	New	+$2.71M	1.46%	19

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Old Port Advisors's GSK Position: Q2 2026 in Review

Old Port Advisors increased its GSK (GSK) stake by 1.3% in Q2 2026, buying an estimated $46.2K and bringing the position to 69,539 shares worth $3.65M. The position accounts for 0.72% of the portfolio, ranked #33.

Old Port Advisors first reported a position in GSK in Q2 2018 and has held it in 31 quarters since. The position peaked at $3.79M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Old Port Advisors held 69,539 shares of GSK worth $3.65M as of Q2 2026.
Old Port Advisors bought 874 GSK shares in Q2 2026, an estimated $46.2K.
GSK made up 0.72% of Old Port Advisors's portfolio in Q2 2026, its #33 holding.
Old Port Advisors first reported a position in GSK in Q2 2018 and has held it in 31 quarters since.
Old Port Advisors's GSK position peaked at $3.79M in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Old Port Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.